CSIMarket Company Name, Ticker, Customers, else..
 
Motus Gi Holdings Inc   (MOTS)
 
Price: $0.0002 $0.00 0.000%
Day's High: $0.00019999999494757503 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: 100 %
Volume (M): 0 52 Wk High: $ 0.10
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 9
 Employees 31
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Business Description


Motus Gi Holdings Inc is a medical technology company that specializes in developing innovative solutions for gastrointestinal (GI) diseases. The company is focused on improving the outcomes of diagnostic and therapeutic procedures performed in the GI tract. Motus Gi Holdings Inc is known for its flagship product, the Pure-Vu System, which is designed to facilitate bowel cleansing prior to colonoscopy procedures. The system utilizes advanced technology to enhance visualization and remove debris, allowing for better examination of the colon. Motus Gi Holdings Inc aims to improve patient care by reducing the need for repeat procedures and complications associated with inadequate bowel preparation.


   Company Address: 1301 East Broward Boulevard Ft. Lauderdale 33301 FL
   Company Phone Number: 541 8000   Stock Exchange / Ticker: MOTS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -6.1%    
BSX   -7.83%    
CNMD   -6.26%    
MDT   -2.35%    
OSUR   -9.5%    
STE   -7.28%    
• View Complete Report
   



Shares

Motus GI Holdings Secures $2.7 Million in Funding through the Exercise of Outstanding Series B Warrant

Published Thu, Feb 22 2024 1:00 PM UTC

Motus GI Holdings Exercises Series B Warrant, Generating $2.7 Million in Proceeds
Fort Lauderdale, FL - Motus GI Holdings, Inc. (Nasdaq: MOTS), a prominent medical technology company specializing in improving endoscopic outcomes and experiences, has recently announced the successful exercise of an outstanding Series B common stock purchase warrant held by an institutiona...
Stock Market Announcement

Motus GI Holdings, Inc Special Stockholders Meeting Adjourned, Impact on Company Shares Unknown

Published Fri, Feb 16 2024 9:15 PM UTC

Motus GI Holdings, Inc. Special Stockholders Meeting Adjourned, Impact on Company Shares Unknown
Motus GI Holdings, Inc. recently announced the adjournment of its special meeting of stockholders, which was held on February 16, 2024. The meeting was adjourned without conducting any business in order to provide stockholders with additional time to vote on a proposal outlin...
Shares

Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering to Enhance Medical Technology Innovations

Published Tue, Dec 19 2023 3:10 AM UTC

Motus GI Holdings, Inc. (Nasdaq: MOTS), a medical technology company specializing in improving endoscopic outcomes and experiences, recently announced the pricing of a public offering that aims to raise approximately $5 million. The offering includes 3,333,334 shares of common stock, Series A common warrants, and Series B common warrants at a combined price of $1.50 per shar...
Product Service News

Motus GI Disrupts Upper GI Procedures with Pure-Vu EVS Gastro: Improving Visualization and Transforming Patient Care

Published Fri, Nov 10 2023 1:01 PM UTC

Motus GI Introduces Pure-Vu EVS Gastro: Revolutionizing Upper GI Procedures
Motus GI Holdings Inc., a pioneering medical technology company, recently announced the successful completion of the first upper gastrointestinal (GI) patient procedure using their FDA cleared Pure-Vu EVS Gastro system. Dr. Brian Hanson, a renowned gastroenterologist and Assistant Professor of Me...
Shares

Motus GI Announces 1-for-15 Reverse Stock Split: Boosting Share Value Amidst Challenging Market Conditions

Published Wed, Nov 1 2023 12:02 PM UTC


Fort Lauderdale, Fla. - Motus GI Holdings, Inc. (NASDAQ: MOTS) has revealed its plan to execute a 1-for-15 reverse stock split of its outstanding common stock. With a focus on enhancing endoscopic outcomes and experiences, Motus GI aims to strengthen its position in the medical technology sector. The company s common stock will begin trading on a split-adjusted basis on...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.01
Price to Sales (Expected) -
Price to Book 0
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.55
Working Capital Ratio 1.8
Leverage Ratio (MRQ) 1.27
Total Debt to Equity 0.75
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.8

Per Share Current
Earnings (TTM) -9.03 $
Revenues (TTM) 0.04 $
Cash Flow (TTM) -
Cash 0.57 $
Book Value 0.36 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 10,548
Net Income per Employee (TTM) -519,419
Receivable Turnover Ratio (TTM) 3.58
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.04

Profitability Ratios Current
Gross Margin (MRQ) 81.25 %
Operating Margin (MRQ) -3165.62 %
Net Margin (MRQ) -11907.81 %
Net Cash Flow Margin (MRQ) -21.88 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.